Mortgage Market Index Down, Purchases Lead

Purchase financing activity was out front of a week-over-week gain in new mortgage business. Government-insured share, meanwhile, was at its widest level in six months.

The U.S. Mortgage Market Index from Mortgage Daily, an indication of upcoming originations based on rate-lock activity at OpenClose, was 131 in the week ended Jan. 26.

Compared to the week that included the Martin Luther King Jr. holiday, the index climbed 18 percent. No adjustments were made to the index for the holiday week.


…read more

From:: Financing

Wall Street’s ‘fear gauge’ quietly climbs to highest level in 5 months as stocks stumble

A measure of volatility on Wall Street on Monday rose to its highest level in more than 5 months as U.S. equity benchmarks dipped and as the yield in a benchmark Treasury note climbed to its highest level in more than three years. The CBOE Volatility Index was up 16% at 12.12, marking its highest level since Aug. 18, 2017, according to FactSet data. The VIX uses bullish and bearish option bets on the S&P 500 index to reflect expected volatility over the coming 30 days, and it typically rises as stocks fall. However, the gauge, sometimes referred to as the fear index, has been abnormally low, trading below its historical average at around 20. To be sure, it is still holding at a level below that historic mean but its recent pick up suggests that investors are betting that volatility will accelerate over the coming days and months. A rise in 10-year Treasury note yield above 2.71% also has drawn attention, because rising rates can undercut appetite for stocks if government paper offer richer yields than risk assets like stocks. Rising yields, President Donald Trump’s State of the Union speech on Tuesday, the Federal Reserve’s updated policy statement on Wednesday and a bevy of earnings set to be released throughout the week could induce choppy trade in an otherwise subdued market. The three main equity benchmarks were under pressure Monday afternoon, with the Dow Jones Industrial Average off 100 points, or 0.4%, at 26,517, while the S&P 500 index retreated by 0.4% at 2,862. The technology-laden Nasdaq Composite Index , sometimes viewed as a proxy for risk appetite, was trading 0.3% lower at 7,483. That said, the uptrend for stocks remains intact with all three benchmarks looking at a monthly return of more than 7%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Senior House Republican Frelinghuysen announces plan to retire

One of the most powerful Republicans in Congress, Rep. Rodney Frelinghuysen of New Jersey, announced Monday he will plans retire from Congress at the end of this term. Frelinghuysen is the chair of the House Appropriations Committee. The Wall Street Journal reported last week that Frelinghuysen was facing the first serious challenge of his 23-year congressional career. Even once-secure Republicans are seen to be at risk in the upcoming midterm elections.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

70% of shoppers will buy groceries online by 2024: Nielsen

Data from Nielsen Holdings PLC and the Food Marketing Institute shows that 70% of grocery shoppers will be buying online in the next five-to-seven years. Previously, Nielsen forecast that a majority of shoppers would purchase groceries online in eight-to-10 years. “Now, the estimated $100 billion spend, which is equivalent to every U.S. household spending $850 online for food and beverage annually, will occur by 2022 or 2024,” the group said in a statement. The results come as Amazon.com Inc. , with its Whole Foods Market acquisition, and Wal-Mart Stores Inc. with its Jet.com purchase, are making an e-commerce grocery push. Nielsen and FMI recommend that grocery retailers rely on a multi-platform approach across both stores and digital channels, consumer data, and improved marketing and promotions to reach customers. The PowerShares Dynamic Food & Beverage Portfolio is up 6.7% for the past year while the S&P 500 index is up 24.7% for the period.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Copyright Royalty Board decision to raise songwriter streaming rates leaves out majority of Pandora’s business

The Copyright Royalty Board of the U.S. Library of Congress decided over the weekend to bump up the amount streaming services like Spotify and Apple Inc. have to pay songwriters for interactive streaming by roughly 44% over the next five years. Under the new ruling, streaming companies will have to pay 15.1% of their revenue to songwriters and music publishers, up from 10.5%. In a note to clients on Monday, Raymond James analyst Justin Patterson wrote that the decision won’t affect advertising, which is the majority of Pandora Media Inc.’s revenue. Pandora shares rose nearly 5% during intraday trade on Monday. “The [Copyright Royalty Board’s] decision to increase interactive rates affects only Pandora’s interactive services _ Pandora Plus and Premium,” Patterson wrote. “Pandora’s ad-supported service, which we project as about 77% of 2017 revenue is classified as radio and is not affected by this decision.” Interactive services are ones where listeners are streaming music on-demand. Pandora shares have declined more than 66% in the last 12 months, while the S&P 500 index is up close to 25% and the Dow Jones Industrial Average is up more than 32%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Celgene chairman to retire after 2 years in the role

Celgene Corp. said Monday Chairman Bob Hugin will retire, effective Feb. 5, after about two years in the role and 19 years with the company. The biopharmaceutical company said Chief Executive Mark Alles will take on the additional role of chairman in Hugin’s place. Hugin was appointed chairman on March 1, 2016. He had joined the company in June 1999 as chief financial officer. The stock fell 1% in morning trade. It has lost 8.3% over the past 12 months, while the iShares Nasdaq Biotechnology ETF has rallied 30.2% and the S&P 500 has climbed 24.5%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Aradigm’s stock plunges to lead Nasdaq losers after Linhaliq’s NDA fails to get approved

Shares of Aradigm Corp. plunged 21% toward a four-month low, after the drug maker said the Food and Drug Administration informed that company that its new drug application (NDA) for its lung infection treatment could not be approved in its current form. The percentage decline was the biggest among stocks listed on the Nasdaq exchange. The FDA’s complete response letter (CRL) for Aradigm’s Linhaliq said the areas of concern included clinical data, human factors validation study and product quality. “We remain confident in the efficacy, safety and quality of Linhaliq and will request a meeting with FDA to discuss the topics covered in the CRL with the view to developing plans to move towards resubmission of the Linhaliq NDA as soon as possible,” said Chief Executive Igor Gonda. The stock plunged 58% over the past three months, while the S&P 500 has climbed 11%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Ballard Power’s stock rockets after upbeat outlook, dispute of short-seller’s report

Shares of Ballard Power Systems Inc. shot up 19% in morning trade Monday, after the fuel cell company provided an upbeat outlook for 2017 results as it disputed a report by a short seller that led to a sharp selloff last week. Ballard said it expects to report “record annual revenue” for 2017. “We believe these results fully validate our long-held belief that Ballard is uniquely positioned to capitalize on the worldwide trend toward zero-emission transportation,” Chief Executive Randy MacEwen said. The stock had tumbled 21% the past two sessions to close Friday at a five-month low, after short-seller Spruce Point Capital Management said the company’s growth ambitions in China were expected to fail from weak partnerships, and reminded investors that a previous China deal resulted in a contract breach and lowered guidance in 2015. Spruce Point said the stock should trade in a range of $1.15 to $2.50 over the long term. Ballard said Monday that some of the statements that the short-seller based its arguments on are “demonstrably false,” while others amounted to “unduly negative speculation” about “well-disclosed” risks. The stock has run up 87% over the past 12 months, while the S&P 500 has gained 25%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

UPDATE: Abeona shares rise 10% on ‘regenerative medicine advanced therapy’ designation from FDA

Abeona Therapeutics Inc. shares rose 10% in heavy Monday morning trade after the company’s cell therapy received a Regenerative Medicine Advanced Therapy designation from the Food and Drug Administration. The designation allows for accelerated approval, among other benefits. Abeona’s cell therapy, EB-101, is being developed for recessive dystrophic epidermolysis bullosa, a rare genetic condition with no cure that is marked by widespread blistering. The condition makes it difficult for patients to eat and can lead to vision loss, disfigurement and aggressive skin cancer, according to the National Institutes of Health. EB-101 aims to re-engineer a patient’s cells to produce collagen, helping reduce blistering and improve healing, Abeona said. The company plans to begin a phase 3 trial for the cell therapy later this year. Company shares have risen 3.5% over the last three months, compared with a 11.3% rise in the S&P 500 and a 13.6% rise in the Dow Jones Industrial Average .

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

U.S. stocks retreat from records ahead of packed week for corporate earnings

U.S. stock indexes opened slightly lower on Monday, pulling back from records ahead of a raft of corporate earnings this week. The Dow Jones Industrial Average declined 38 points, or 0.1%, to 26,572. The S&P 500 fell 7 points, or 0.23%, to 2,866. The Nasdaq Composite Index was down 20 points, or 0.3%, to 7,485. All three major indexes closed at records on Friday, with each gauge posting their fourth straight weekly gain. The next few days will prove particularly busy as investors will look ahead to President Donald Trump’s State of the Union address and the Federal Reserve’s two-day meeting. Also, a quarter of the S&P 500 companies are set to report their earnings this week.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News